• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGM454520J
Device Problems Patient-Device Incompatibility (2682); Migration (4003)
Event Date 12/17/2020
Event Type  Injury  
Manufacturer Narrative
The actual event date is unknown.Therefore, (b)(6) 2020 is used as the event date.Code "other" was selected as the medical device remains implanted.Return not possible.According to the gore® tag® conformable thoracic stent graft with active control system for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to: aortic expansion (e.G., aneurysm, false lumen, landing zone, lesion), endoleak, migration.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
The following was reported to gore: on an unknown date, a stent graft which was a potential for a gore® tag® conformable thoracic stent graft with active control system was implanted (details unknown).On (b)(6) 2020, a reintervention was performed.A gore® tag® conformable thoracic stent graft with active control system was implanted distally of the previous implanted device which was potential for the gore® tag® conformable thoracic stent graft with active control system.It is unknown why this reintervention was performed.(this event was captured in medwatch report number 2017233-2024-04860).During a follow-up, an aneurysm in a thoracoabdominal was enlarged gradually.On an unknown date, the gore® tag® conformable thoracic stent graft with active control system which was implanted on (b)(6) 2020 moved proximally (distance unknown) and a distal type i endoleak and the aneurysm enlargement (amount unknown) were confirmed.On (b)(6) 2024, a reintervention was performed.The first gore® tag® conformable thoracic stent graft with active control system was implanted distally.However, an angiography revealed the endoleak remained.The second gore® tag® conformable thoracic stent graft with active control system was implanted and the endoleak was resolved.The patient tolerated the procedure.
 
Manufacturer Narrative
H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.H6: code c21 was updated to code c19.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
asami aizawa
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key19188640
MDR Text Key341116886
Report Number2017233-2024-04873
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/27/2023
Device Catalogue NumberTGM454520J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/02/2024
Initial Date FDA Received04/25/2024
Supplement Dates Manufacturer Received04/02/2024
Supplement Dates FDA Received05/10/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/27/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient SexMale
-
-